Helicon opens $4m IPO

PERTH-BASED pharmaceutical products commercialisation specialist, Helicon Group Ltd, has launched its initial public offer, aiming to raise up to $4 million to fund market research and pursuit of new opportunities in the Chinese and north Asian markets.